Method validation for each species [Bioanalytics]

posted by janmacek – Czech Republic, 2016-05-11 15:09 (3701 d 19:06 ago) – Posting: # 16293
Views: 3,089

Dear all,

we are planning validation of a bioanalytical method for the determination of a drug candidate in plasma. This method should be used for the analysis of samples from various species (rat, mouse, dog, etc.). The European Guideline states that full validation should be performed for each species and matrix concerned, while the FDA guideline states that partial validation is required for the change of species within matrix.

What is your experience with this topic? Is the approach really different in Europe and US?

With best regards,

Jan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
276 visitors (0 registered, 276 guests [including 30 identified bots]).
Forum time: 10:15 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5